GlassScriptPhysician profile
Manmohan K Ghanta
NPI 1932197530
$1,535.96
in general payments reported to CMS, 2019-2025
22 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $57.57 · 2021: $205 · 2022: $337 · 2023: $118 · 2024: $309 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $717.11 | 2019-2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $178.84 | 2021-2022 | |
| Kerecis Limited | $164.95 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $74.98 | 2020-2022 | |
| Solventum Corporation | $44.90 | 2025 | V.A.C. Veraflo, Prevena, Promogran Prisma |
| Tela Bio, INC. | $37.78 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Bk Medical Holding Company INC. | $32.95 | 2024 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Merck Sharp & Dohme LLC | $30.64 | 2024 | Lynparza, Keytruda |
| Zyla Life Sciences, INC. | $29.97 | 2019 | |
| Ethicon US, LLC | $29.12 | 2020-2022 | |
| Merit Medical Systems INC | $28.05 | 2023-2024 | Savi Scout |
| Bard Peripheral Vascular, INC. | $19.42 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $19.04 | 2025 | |
| Hologic Sales and Service, LLC | $18.06 | 2024 | Localizer, Trunode |
| Rti Surgical, INC | $17.50 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $15.31 | 2022 | |
| Endogastric Solutions, INC | $15.02 | 2022 | |
| Elucent Medical | $13.56 | 2025 | |
| La Jolla Pharmaceutical Company | $13.06 | 2023 | Xerava |
| Polynovo North America LLC | $12.27 | 2022 | |
| Abbott Laboratories | $12.25 | 2019 | |
| Medtronic, INC. | $11.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manmohan Ghanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.